Lena Schütte

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country

Christina W. Obiero, Augustin G. W. Ndiaye, Antonella Silvia Sciré et al. · Frontiers in Immunology · 2017 · 109 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Both Thioredoxin 2 and Glutaredoxin 2 Contribute to the Reduction of the Mitochondrial 2-Cys Peroxiredoxin Prx3

Eva-Maria Hanschmann, Maria Lönn, Lena Schütte et al. · Journal of Biological Chemistry · 2010 · 108 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Vertebrate-specific glutaredoxin is essential for brain development

Lars Bräutigam, Lena Schütte, José R. Godoy et al. · Proceedings of the National Academy of Sciences · 2011 · 89 citations · Full text

Life Sciences, Developmental Biology, Neuroscience +15

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial

Odile Launay, Augustin G. W. Ndiaye, Valentino Conti et al. · Frontiers in Immunology · 2019 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response

Alica K. Beutel, Lena Schütte, Jeanette Scheible et al. · Cancers · 2021 · 61 citations · Full text

Medicine, Oncology, Pharmacology +15